Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
LTS enables pharmaceutical partners to bring non-invasive drug delivery products to market using its proprietary TTS, OTF, MAP and OBDS platforms. Its technologies are used in multiple approved therapies worldwide across a broad range of indications. The company has supported launches such as the first generic Suboxone® sublingual film in the US and various transdermal/oral thin film drugs for pain management and CNS disorders.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on LTS Lohmann Therapie-Systeme.